Your browser doesn't support javascript.
loading
Editorial: can serum triiodothyronine-to-thyroxine (T3/T4) ratio predict safety and efficacy of biologic treatment in IBD? Authors' reply.
Bertani, Lorenzo; Pugliese, Daniela; Tricò, Domenico; Costa, Francesco; Blandizzi, Corrado.
Affiliation
  • Bertani L; Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.
  • Pugliese D; CEMAD - IBD Unit, Department of Medical and Surgical Sciences, "A. Gemelli" University Hospital, Rome, Italy.
  • Tricò D; Department of Surgical, Medical and Molecular Pathology and Critical Care Medicine, University of Pisa, Pisa, Italy.
  • Costa F; Institute of Life Sciences, Sant'Anna School of Advanced Studies, Pisa, Italy.
  • Blandizzi C; IBD Unit, Department of General Surgery and Gastroenterology, Pisa University Hospital, Pisa, Italy.
Aliment Pharmacol Ther ; 53(2): 348-349, 2021 01.
Article in En | MEDLINE | ID: mdl-33368507
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Biological Products / Inflammatory Bowel Diseases Type of study: Prognostic_studies / Risk_factors_studies Limits: Aged / Humans Language: En Journal: Aliment Pharmacol Ther Journal subject: FARMACOLOGIA / GASTROENTEROLOGIA / TERAPIA POR MEDICAMENTOS Year: 2021 Document type: Article Affiliation country: Italy Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Biological Products / Inflammatory Bowel Diseases Type of study: Prognostic_studies / Risk_factors_studies Limits: Aged / Humans Language: En Journal: Aliment Pharmacol Ther Journal subject: FARMACOLOGIA / GASTROENTEROLOGIA / TERAPIA POR MEDICAMENTOS Year: 2021 Document type: Article Affiliation country: Italy Country of publication: United kingdom